Exploratory Study on the Efficacy of Boosted CT Myelography
Not Applicable
Recruiting
- Conditions
- cerebrospinal fluid hypovolemia
- Registration Number
- JPRN-jRCTs061230076
- Lead Sponsor
- Eiichi Nakai
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 6
Inclusion Criteria
(1) Patients whose cerebrospinal fluid pressure has been confirmed to be less than 10 cmH2O at least once in the past and who are strongly suspected of having cerebrospinal fluid depletion.
(2) Patients in whom leakage sites cannot be identified by CT myelography
(3) Age 18 and above at the time of consent acquisition (gender unspecified)
Exclusion Criteria
(1) Patients with suspected symptoms of contrast agent allergy in the past
(2) Patients with other acute illnesses
(3) Pregnant women
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The percentage of identified leakage sites of cerebrospinal fluid using boosted CT Myelography.
- Secondary Outcome Measures
Name Time Method (1) Complications such as bleeding and neurological disorders associated with the implementation of boosted CT myelography.<br>(2) Side effects such as headache, dizziness, nausea, and fever associated with intrathecal injection of ARTCEREB.<br>(3) Overall mortality.<br>(4) Other adverse events.